Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: A prospective, randomized, double-blind multicenter study

被引:5
作者
Mahjoub, Lobna [1 ]
Youssef, Rym [1 ]
Yaakoubi, Hajer [1 ]
Ben Salah, Houda [1 ]
Jaballah, Rahma [1 ]
Mejri, Moez [1 ]
Sekma, Adel [2 ]
Trabelsi, Imen [2 ]
Nouira, Semir [2 ]
Khrouf, Mariem [3 ]
Ben Soltane, Houda [3 ]
Mezgar, Zied [3 ]
Boukadida, Lotfi [1 ]
Zorgati, Asma [1 ]
Boukef, Riadh [1 ]
机构
[1] Sahloul Univ Hosp, Emergency Dept, Sousse 4011, Tunisia
[2] Monastir Univ, Res Lab LR12SP18, Monastir 5019, Tunisia
[3] Farhat Hached Univ Hosp, Emergency Dept, Sousse 4031, Tunisia
关键词
Melatonin; Zinc; Vitamin C; Vitamin D; Covid-19; Emergency department; INFECTION; ZINC;
D O I
10.1016/j.explore.2023.06.009
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Melatonin, zinc, and multivitamins are among most recommended supplements in the fight against coronavirus disease 2019 (COVID-19). We aimed to examine the efficacy and safety of this association in the treatment of COVID-19 and COVID-like illnesses. Methods: We conducted a multicenter prospective, randomized, double-blind, controlled trial. Patients with no medical history consulting the emergency department for covid and covid-like illness and who were not hospitalized were included. Patients were assigned in a 1:1 ratio to the treatment or the placebo group. The primary outcome was studying the effectiveness of zinc multivitamin supplement and melatonin in the treatment of COVID and -like illnesses symptoms' according to the time from randomization to clinical improvement. The prespecified secondary outcomes were date of disappearance of symptoms present on admission, appearance of an adverse effect due to the administration of the treatment, number of patients developing complications, requiring hospitalization, requiring respiratory support. Results: One hundred sixty four patients were eligible for the study and were randomized to either the treatment group or the placebo group. Overall, 128 of the 164 patients had a PCR for SARS-CoV-2, yielding a positive PCR result in 49.1% of them. Regarding the disappearance of all initial presenting symptoms: on the 5(th) day of the follow-up, there was a significant difference between the two groups with a p value 0.04;On the 10th day, there was a significant difference too with p value of 0.038. There were no significant differences between the two groups in recovery during the 15th day of follow-up p>0.5. Finally, 100% of patients fully recovered in the treatment group vs 98.8% in the placebo group. No severe adverse events were reported throughout the trial. Conclusions: Our results showed that daily doses of Melatonin, zinc and vitamins did significantly reduce the duration of symptoms accelerating its disappearance among patients consulting with COVID-19 or COVID-19 like illness.
引用
收藏
页码:95 / 100
页数:6
相关论文
共 50 条
  • [41] Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID)
    Horcajada, Juan P.
    Aldonza, Rebeca
    Real, Monica
    Castaneda-Espinosa, Silvia
    Sendra, Elena
    Gomez-Junyent, Joan
    Lopez-Montesinos, Inmaculada
    Gomez-Zorrilla, Silvia
    Brianso, Silvia
    Duran-Taberna, Montserrat
    Fernandez, Andres
    Tarrago, Cristina
    Auguet-Quintilla, Teresa
    [J]. PNEUMONIA, 2024, 16 (01)
  • [42] Fecal microbiota transplantation alleviates mild-moderate COVID-19 associated diarrhoea and depression symptoms: A prospective study of a randomized, double-blind clinical trial
    Jiang, Xia
    Gao, Xian
    Ding, Jiaqi
    Pang, Bo
    Pei, Yongbin
    Zhao, Zifeng
    Zhao, Ning
    Wang, Zibin
    Chen, Chengyang
    Gao, Da
    Yan, Fu
    Wang, Feifan
    Liu, Chengcheng
    Zhang, Zheng
    Li, Zhongxin
    Zhao, Zengren
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (08)
  • [43] Traditional Vietnamese medicine Kovir capsule in patients with mild COVID-19: A double-blind randomized controlled trial
    Huynh Nguyen Loc
    Truong Thi Ngoc Lan
    Dinh Thi Lan Huong
    Nguyen Thanh Tuyen
    Tran Minh Quang
    Ly Minh Dao
    Pham Hung Van
    Nguyen Lam Vuong
    [J]. PHYTOTHERAPY RESEARCH, 2022, 36 (07) : 2878 - 2888
  • [44] Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients
    De Boeck, Ilke
    Cauwenberghs, Eline
    Spacova, Irina
    Gehrmann, Thies
    Eilers, Tom
    Delanghe, Lize
    Wittouck, Stijn
    Bron, Peter A.
    Henkens, Tim
    Gamgami, Imane
    Simons, Alix
    Claes, Ingmar
    Marien, Joachim
    Arien, Kevin K.
    Bakokimi, Diana
    Loens, Katherine
    Jacobs, Kevin
    Ieven, Margareta
    Bruijning-Verhagen, Patricia
    Delputte, Peter
    Coenen, Samuel
    Verhoeven, Veronique
    Lebeer, Sarah
    [J]. MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [45] Nitazoxanide in Patients Hospitalized With COVID-19 Pneumonia: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
    Rocco, Patricia R. M.
    Silva, Pedro L.
    Cruz, Fernanda F.
    Tierno, Paulo F. G. M. M.
    Rabello, Eucir
    Junior, Jefiton Cordeiro
    Haag, Firmino
    de avila, Renata E.
    da Silva, Joana D. G.
    Mamede, Mariana M. S.
    Buchele, Konrad S.
    Barbosa, Luiz C. V.
    Cabral, Anna C.
    Junqueira, Antonio A. F.
    Araujo-Filho, Joao A.
    da Costa, Lucianna A. T. J.
    Alvarenga, Pedro P. M.
    Moura, Alexandre S.
    Carajeleascow, Ricardo
    de Oliveira, Mirella C.
    Silva, Roberta G. F.
    Soares, Cynthia R. P.
    Fernandes, Ana Paula S. M.
    Fonseca, Flavio Guimaraes
    Camargos, Vidyleison Neves
    Reis, Julia de Souza
    Franchini, Kleber G.
    Luiz, Ronir R.
    Morais, Sirlei
    Sverdloff, Carlos
    Martins, Camila Marinelli
    Felix, Nathane S.
    Mattos-Silva, Paula
    Nogueira, Caroline M. B.
    Caldeira, Dayene A. F.
    Pelosi, Paolo
    Lapa-e-Silva, Jose R.
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [46] The remote intercessory prayer, during the clinical evolution of patients with COVID-19, randomized double-blind clinical trial
    Soubihe Junior, Nathan Valle
    Bersch-Ferreira, Angela Cristine
    Tokunaga, Samira Martins
    Lopes, Luciana Alves
    Cavalcanti, Alexandre Biasi
    Bernadez-Pereira, Sabrina
    [J]. HELIYON, 2023, 9 (11)
  • [47] The effects of colchicine on hospitalized COVID-19 patients: A randomized, double-blind, placebo-controlled clinical trial
    Kasiri, Hossein
    Ghazaiean, Mobin
    Rouhani, Nima
    Naderi-behdani, Fahimeh
    Ghazaeian, Monireh
    Ghodssi-Ghassemabadi, Robabeh
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (02) : 124 - 131
  • [48] Bromhexine for Post-exposure COVID-19 Prophylaxis: A Randomized, Double-blind, Placebo-controlled Trial
    Tolouian, Ramin
    Moradi, Omid
    Mulla, Zuber D.
    Ziaie, Shadi
    Haghighi, Mehrdad
    Esmaily, Hadi
    Amini, Hossein
    Hassanpour, Rezvan
    Poorheidar, Elham
    Kouchek, Mehran
    Manafi-Rasi, Alireza
    Sali, Shahnaz
    Abolghasemi, Sara
    Tehrani, Shabnam
    Tolouian, Audrey C.
    Zali, Alireza
    Sistanizad, Mohammad
    [J]. JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2022, 15 (08)
  • [49] Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial
    Amirreza Roostaei Firozabad
    Zohreh Akhoundi Meybodi
    Seyed Ruhollah Mousavinasab
    Adeleh Sahebnasagh
    Mohsen Gholinataj Jelodar
    Iman Karimzadeh
    Solomon Habtemariam
    Fatemeh Saghafi
    [J]. BMC Infectious Diseases, 21
  • [50] Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial
    Firozabad, Amirreza Roostaei
    Meybodi, Zohreh Akhoundi
    Mousavinasab, Seyed Ruhollah
    Sahebnasagh, Adeleh
    Jelodar, Mohsen Gholinataj
    Karimzadeh, Iman
    Habtemariam, Solomon
    Saghafi, Fatemeh
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)